Investment banks compete for biotech business

11/13/2012 | Xconomy

JP Morgan, Bank of America/Merrill Lynch and Goldman Sachs are among the investment banks underwriting biotech companies this year, Securities and Exchange Commission filings show. Other investors include Needham & Co., BMO Capital Markets, Stifel Nicolaus and Oppenheimer. The financing of Regulus Therapeutics, which does not have a drug in clinical trials, shows that Wall Street may be willing to take more risks on biotech, Luke Timmerman writes.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations